Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 May 29.
doi: 10.3322/caac.70016. Online ahead of print.

Reirradiation: Standards, challenges, and patient-focused strategies across tumor types

Affiliations
Free article
Review

Reirradiation: Standards, challenges, and patient-focused strategies across tumor types

Arnaud Beddok et al. CA Cancer J Clin. .
Free article

Abstract

Reirradiation (reRT), defined as administering a course of radiation therapy to a specific area previously irradiated, is an evolving treatment strategy for locoregionally recurrent cancer that offers significant potential and poses inherent challenges. Advances in such techniques as intensity-modulated and stereotactic body radiation therapy have improved precision, making reRT a viable option for complex scenarios previously deemed high-risk. Nevertheless, reRT remains associated with substantial risks-including life-threatening side effects, functional impairments, and psychosocial effects-which must be carefully balanced against the patient's overall health and the likelihood of achieving cancer control or palliation. Patient selection is essential to optimize outcomes while mitigating risks. Decisions should account for tumor characteristics at the time of primary diagnosis and recurrence, elapsed time since prior treatment, the possibility of delivering meaningful doses to the tumor, and the cumulative irradiation tolerance of normal tissues. Advanced imaging modalities, such as functional magnetic resonance imaging and fluorine-18-labeled fluorodeoxyglucose-positron emission tomography, are important for distinguishing recurrences from treatment-induced changes, refining treatment targets, and minimizing exposure to healthy tissue. Combined treatment with systemic regimens-targeted therapies and immunotherapy in particular-offers promising opportunities but requires coordination to manage side effects. Standardized guidelines, such as those from the European Society of Therapeutic Radiology and Oncology-European Society for Research and Treatment of Cancer, are essential for improving the consistency of reporting, guiding clinical decision making, and fostering patient-centered care. Multidisciplinary collaboration and ongoing research, particularly through clinical trials, are central to fully exploiting reRT strategies. In addition, the development of innovative techniques, such as proton therapy, would likely enable safer treatments. These efforts aim to improve the therapeutic balance of reRT, enhancing outcomes and quality of life.

Keywords: advanced imaging techniques; decision‐making; locoregional recurrence; radiation oncology; reirradiation.

PubMed Disclaimer

References

REFERENCES

    1. Andratschke N, Willmann J, Appelt AL, et al. European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re‐irradiation: definition, reporting, and clinical decision making. Lancet Oncol. 2022;23(10):e469‐e478. doi:10.1016/s1470-2045(22)00447-8
    1. Peters LJ, O’Sullivan B, Giralt J, et al. Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02. J Clin Oncol. 2010;28(18):2996‐3001. doi:10.1200/jco.2009.27.4498
    1. Kaidar‐Person O, Giasafaki P, Boersma L, et al. Mapping the location of local and regional recurrences according to breast cancer surgery and radiation therapy: results from EORTC 22922/10925. Radiother Oncol. 2023;185:109698. doi:10.1016/j.radonc.2023.109698
    1. Sturdza A, Pötter R, Fokdal LU, et al. Image guided brachytherapy in locally advanced cervical cancer: improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study. Radiother Oncol. 2016;120:428‐433. doi:10.1016/radonc.2016.03.011
    1. Dijkstra EA, Nilsson PJ, Hospers GAP, et al. Locoregional failure during and after short‐course radiotherapy followed by chemotherapy and surgery compared with long‐course chemoradiotherapy and surgery: a 5‐year follow‐up of the RAPIDO trial. Ann Surg. 2023;278(4):e766‐e772. doi:10.1097/sla.0000000000005799

LinkOut - more resources